Megumi Matsuda

Megumi Matsuda

Auto-generated profile, based on publicly available information

Megumi Matsuda

Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2018 in Journal of Anesthesia
Verified
Journal Article
Closed access
PDF file
MMMegumi Matsuda
Megumi Matsuda
YHYul Huh
Yul Huh
RJRu-Rong Ji
Ru-Rong Ji

19 February 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ZWZilong Wang
Zilong Wang
CJChangyu Jiang
Changyu Jiang
QHQianru He
Qianru He
MMMegumi Matsuda
Megumi Matsuda
QHQingjian Han
Qingjian Han
RJRu-Rong Ji
Ru-Rong Ji
Emerging immunotherapies with monoclonal antibodies against programmed cell death protein–1 (PD-1) have shown success in treating cancers. However, PD-1 signaling in neurons is largely unknown. We recently reported that dorsal root ganglion (DRG) primary sensory neurons express PD-1 and activation of PD-1 inhibits neuronal excitability and pain. Opioids are mainstay treatments for cancer pain, and morphine produces antinociception via mu opioid receptor (MOR). Here, we report that morphine antinociception and MOR signaling require neuronal PD-1. Morphine-induced antinociception after systemic or intrathecal injection was compromised in Pd1−/− mice. Morphine antinociception was also diminished in wild-type mice after intravenous or intrathecal administration of nivolumab, a clinically used anti–PD-1 monoclonal antibody. In mouse models of inflammatory, neuropathic, and cancer pain, spinal morphine antinociception was compromised in Pd1−/− mice. MOR and PD-1 are coexpressed in sensory neurons and their axons in mouse and human DRG tissues. Morphine produced antinociception by (i) suppressing calcium currents in DRG neurons, (ii) suppressing excitatory synaptic transmission, and (iii) inducing outward currents in spinal cord neurons; all of these actions were impaired by PD-1 blockade in mice. Loss of PD-1 also enhanced opioid-induced hyperalgesia and tolerance and potentiates opioid-induced microgliosis and long-term potentiation in the spinal cord in mice. Last, intrathecal infusion of nivolumab inhibited intrathecal morphine-induced antinociception in nonhuman primates. Our findings demonstrate that PD-1 regulates opioid receptor signaling in nociceptive neurons, leading to altered opioid-induced antinociception in rodents and nonhuman primates.

1 October 2020 in iScience
Verified
Journal Article
Open access
CJChangyu Jiang
Changyu Jiang
ZWZilong Wang
Zilong Wang
CDChristopher R. Donnelly
Christopher R. Donnelly
KWKaiyuan Wang
Kaiyuan Wang
AAAmanda S. Andriessen
Amanda S. Andriessen
RJRu-Rong Ji
Ru-Rong Ji
The immune checkpoint inhibitor programmed cell death protein 1 (PD-1) plays a critical role in immune regulation. Recent studies have demonstrated functional PD-1 expression in peripheral sensory neurons, which contributes to neuronal excitability, pain, and opioid analgesia. Here we report neuronal expression and function of PD-1 in the central nervous system (CNS), including the spinal cord, thalamus, and cerebral cortex. Notably, GABA-induced currents in spinal dorsal horn neurons, thalamic neurons, and cortical neurons are suppressed by the PD-1-neutralizing immunotherapeutic Nivolumab in spinal cord slices, brain slices, and dissociated cortical neurons. Reductions in GABA-mediated currents in CNS neurons were also observed in Pd1−/− mice without changes in GABA receptor expression. Mechanistically, Nivolumab binds spinal cord neurons and elicits ERK phosphorylation to suppress GABA currents. Finally, both GABA-mediated analgesia and anesthesia are impaired by Pd1 deficiency. Our findings reveal PD-1 as a CNS-neuronal inhibitor that regulates GABAergic signaling and GABA-mediated behaviors.

14 March 2019 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
MMMegumi Matsuda
Megumi Matsuda
HTHitomi Takemura
Hitomi Takemura
AYAyahiro Yamashita
Ayahiro Yamashita
YMYutaka Matsuoka
Yutaka Matsuoka
TSTeiji Sawa
Teiji Sawa
FAfumimasa amaya
fumimasa amaya